
Investments
9Portfolio Exits
3Funds
2About Redview Capital
Redview Capital is a private equity fund that focuses on traditional growth capital with investments in consumer goods, advanced manufacturing, clean energy, and new materials in China.
Latest Redview Capital News
Jun 21, 2022
MegaRobo Technologies, a Beijing, China-based provider of automation solutions, raised $300M in Series C funding.The round was led by Goldman Sachs Asset Management, Asia Investment Capital, and GGV Capital, with participation from Sinovation Ventures, Pavilion Capital, Starr Capital, U-Member Capital, RedView Capital, Harvest Capital and Taihe Capital.Adopted in multiple countries around the world, MegaRobo’s products can improve efficiency for clients compared to conventional approach in various life sciences applications including antibody selection, cell line development and molecular screening.The company has collaborated with life sciences companies to build the infrastructure and platform to optimize R&D process and improve efficiency.In cell & gene therapy, MegaRobo has jointly developed integrated automation solutions for synthetic biology and biopharmaceutical R&D with Agilent Technologies. Disclaimer: This story is auto-aggregated & summarized by a computer program and has not been created by StartupAround.
Redview Capital Investments
9 Investments
Redview Capital has made 9 investments. Their latest investment was in MegaRobo as part of their Series C on June 6, 2022.

Redview Capital Investments Activity

Date | Round | Company | Amount | New? | Co-Investors | Sources |
---|---|---|---|---|---|---|
6/15/2022 | Series C | MegaRobo | $300M | Yes | 3 | |
6/8/2022 | Series B - IV | |||||
12/12/2021 | Series B | |||||
10/26/2021 | Series A | |||||
6/8/2021 | Series C |
Date | 6/15/2022 | 6/8/2022 | 12/12/2021 | 10/26/2021 | 6/8/2021 |
---|---|---|---|---|---|
Round | Series C | Series B - IV | Series B | Series A | Series C |
Company | MegaRobo | ||||
Amount | $300M | ||||
New? | Yes | ||||
Co-Investors | |||||
Sources | 3 |
Redview Capital Portfolio Exits
3 Portfolio Exits
Redview Capital has 3 portfolio exits. Their latest portfolio exit was Dingdang Health on September 14, 2022.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
---|---|---|---|---|---|
9/14/2022 | IPO | Public | 3 | ||
Date | 9/14/2022 | ||
---|---|---|---|
Exit | IPO | ||
Companies | |||
Valuation | |||
Acquirer | Public | ||
Sources | 3 |
Redview Capital Acquisitions
1 Acquisition
Redview Capital acquired 1 company. Their latest acquisition was Source Photonics on September 27, 2016.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
---|---|---|---|---|---|---|
9/27/2016 | Series D | $180M | Acq - Fin | 1 |
Date | 9/27/2016 |
---|---|
Investment Stage | Series D |
Companies | |
Valuation | |
Total Funding | $180M |
Note | Acq - Fin |
Sources | 1 |
Redview Capital Fund History
2 Fund Histories
Redview Capital has 2 funds, including Redview Capital LP.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
---|---|---|---|---|---|
9/14/2015 | Redview Capital LP | Diversified Private Equity | Closed | 1 | |
Redview Capital II LP |
Closing Date | 9/14/2015 | |
---|---|---|
Fund | Redview Capital LP | Redview Capital II LP |
Fund Type | Diversified Private Equity | |
Status | Closed | |
Amount | ||
Sources | 1 |
Redview Capital Team
1 Team Member
Redview Capital has 1 team member, including current Managing Director, Jianming Yu.
Name | Work History | Title | Status |
---|---|---|---|
Jianming Yu | Managing Director | Current |
Name | Jianming Yu |
---|---|
Work History | |
Title | Managing Director |
Status | Current |
Loading...